MAOA - monoamine oxidase A Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 414424
About MAOA
Primary_assembly X: 38,929,232-39,006,214 forward strand.Sscrofa11.1:CM000830.5
This gene has 6 transcripts (splice variants), 146 orthologues and 8 paralogues. Broad expression in lung (RPKM 91.9), kidney (RPKM 87.) and 8 other tissues.
MAOA Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001001640.1 | NP_001001640.1 | amine oxidase [flavin-containing] A |
MAOA Protein Structure
YobN
YobN: COG1231 (13 - 462)
- 0
- 100
- 200
- 300
- 400
- 500
- 527 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
amine oxidase [flavin-containing] A |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(29)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14536 | Methylene Blue | Inhibitor | 95.05% | Unkown |
| HY-14199 | Selegiline hydrochloride | Inhibitor | 99.96% | Unkown |
| HY-12723 | Apomorphine | 99.48% | Unkown | |
| HY-14280 | Entacapone | Inhibitor | 99.97% | Yes |
| HY-14197A | Clorgyline hydrochloride | Inhibitor | 99.92% | Unkown |
| HY-N0159 | Paeonol | 99.98% | Unkown | |
| HY-B1018A | Phenelzine sulfate | Inhibitor | 99.96% | Unkown |
| HY-A0091A | Pargyline | Inhibitor | 99.92% | Unkown |
| HY-70057 | Safinamide | Inhibitor | 99.86% | Yes |
| HY-A0091 | Pargyline hydrochloride | Inhibitor | 99.91% | Unkown |
| HY-B1359 | Methylene blue trihydrate | Inhibitor | 98.0% | Yes |
| HY-14197 | Clorgyline | Inhibitor | 99.76% | Unkown |
| HY-B0534 | Moclobemide | Inhibitor | 99.12% | Yes |
| HY-70057A | Safinamide mesylate | Inhibitor | 99.07% | Yes |
| HY-14855B | Tedizolid phosphate | Inhibitor | 99.61% | Yes |
| HY-D0958 | Methylene blue hydrate | Inhibitor | / | Unkown |
| HY-B0678 | Metaxalone | 99.77% | Unkown | |
| HY-14196 | Toloxatone | Inhibitor | 98.11% | Unkown |
| HY-N0159R | Paeonol (Standard) | 99.98% | Unkown | |
| HY-B1558A | Bifemelane hydrochloride | Inhibitor | 99.86% | Unkown |
| HY-100679 | Pirlindole | Inhibitor | 98.90% | Unkown |
| HY-14895 | Fabomotizole | 99.96% | Unkown | |
| HY-14198 | Selegiline | Inhibitor | / | Unkown |
| HY-14280R | Entacapone (Standard) | Inhibitor | 99.24% | Unkown |
| HY-100679A | Pirlindole mesylate | Inhibitor | / | Unkown |
| HY-12723R | Apomorphine (Standard) | / | Unkown | |
| HY-B0678R | Metaxalone (Standard) | / | Unkown | |
| HY-W018475 | Rizatriptan | Agonist | / | Unkown |
| HY-14280A | Entacapone sodium salt | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(7)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-N0529 | Rosmarinic acid | 99.73% | Phase 3 | |
| HY-154977 | ETAP | Inhibitor | / | Phase 3 |
| HY-129388B | Pulrodemstat benzenesulfonate | Inhibitor | 99.64% | Phase 2 |
| HY-129388A | Pulrodemstat | Inhibitor | 98.86% | Phase 2 |
| HY-13339 | Brofaromine | Inhibitor | 99.60% | Phase 2 |
| HY-129388 | Pulrodemstat Methylbenzenesulfonate | Inhibitor | / | Phase 2 |
| HY-100178 | CX-157 | Inhibitor | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(127)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-W008566 | Norharmane | Inhibitor | 99.93% | Unkown |
| HY-B1311 | Proadifen hydrochloride | 99.95% | Unkown | |
| HY-Y1322 | Triphenyl phosphate | 99.67% | Unkown | |
| HY-N2554 | Osthenol | 99.15% | Unkown | |
| HY-N0126 | Xanthone | Inhibitor | 99.97% | Unkown |
| HY-W015490 | 1,4-Naphthoquinone | Inhibitor | 99.97% | Unkown |
| HY-14536A | Methylene blue (purity≥70%) | Inhibitor | 95.0% | Unkown |
| HY-110130 | RN-1 dihydrochloride | Inhibitor | 99.21% | Unkown |
| HY-E70074 | Monoamine oxidase, plasma | / | Unkown | |
| HY-N4177 | Rubrofusarin gentiobioside | Inhibitor | 99.04% | Unkown |
| HY-164099 | LSD1/HDAC6-IN-2 | Inhibitor | 99.66% | Unkown |
| HY-19333 | OG-L002 | Inhibitor | 99.55% | Unkown |
| HY-124591 | TC-2153 | Inhibitor | 98.19% | Unkown |
| HY-N12485 | MAO-A inhibitor 1 | Inhibitor | 98.55% | Unkown |
| HY-16677A | Mofegiline hydrochloride | Inhibitor | 99.57% | Unkown |
| HY-131036 | MAO-IN-M30 dihydrochloride | Inhibitor | 98.48% | Unkown |
| HY-14201 | Lazabemide | Inhibitor | 99.95% | Unkown |
| HY-D0004 | Azure B | Inhibitor | 99.87% | Unkown |
| HY-N4246 | Bacopaside I | 99.20% | Unkown | |
| HY-100588 | VU0364770 | Agonist | 99.94% | Unkown |
| HY-137570 | Ethyl homovanillate | Inhibitor | 98.41% | Unkown |
| HY-149213 | LSD1/TLK1-IN-1 | 99.20% | Unkown | |
| HY-W655727 | (-)-2-Phenylpropylamine | Inhibitor | 98.44% | Unkown |
| HY-125515 | Tetrahydroharmine | Inhibitor | 99.61% | Unkown |
| HY-100027A | Ro 41-1049 hydrochloride | Inhibitor | 99.57% | Unkown |
| HY-121072 | ASS234 | Inhibitor | 99.6% | Unkown |
| HY-145259 | HDAC6-IN-3 | Inhibitor | 98.0% | Unkown |
| HY-149408 | MAOA-IN-1 | Inhibitor | 98.24% | Unkown |
| HY-N0126R | Xanthone (Standard) | Inhibitor | 99.99% | Unkown |
| HY-W015490S | 1,4-Naphthoquinone-d6 | Inhibitor | 99.20% | Unkown |
| HY-W049881 | 9-Methyl-β-carboline | 99.86% | Unkown | |
| HY-14260 | RS 8359 | Inhibitor | 97.35% | Unkown |
| HY-101578 | 2614W94 | Inhibitor | 99.76% | Unkown |
| HY-114620 | MAO-B-IN-55 | Inhibitor | 98.10% | Unkown |
| HY-120017 | Befloxatone | Inhibitor | / | Unkown |
| HY-14280S | Entacapone-d10 | Inhibitor | 98.6% | Unkown |
| HY-151466 | HIF-1α-IN-5 | Inhibitor | 99.95% | Unkown |
| HY-151596 | MAO-A/5-HT2AR-IN-1 | Inhibitor | 99.71% | Unkown |
| HY-156255 | MAO-B-IN-25 | Inhibitor | 99.11% | Unkown |
| HY-70057S1 | Safinamide-d4-1 | Inhibitor | 98.90% | Unkown |
| HY-B1018AS | Phenelzine-d5 sulfate | Inhibitor | 99.97% | Unkown |
| HY-W010130 | 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone | Inhibitor | 99.96% | Unkown |
| HY-W275048 | MAO-A inhibitor 3 | Inhibitor | 99.85% | Unkown |
| HY-Y1322S | Triphenyl phosphate-d15 | 99.74% | Unkown | |
| HY-100027 | Ro 41-1049 | Inhibitor | / | Unkown |
| HY-100679B | (R)-Pirlindole mesylate | Inhibitor | / | Unkown |
| HY-106041A | Sercloremine hydrochloride | Inhibitor | / | Unkown |
| HY-106972 | SL-251131 | Inhibitor | / | Unkown |
| HY-108048 | Desoxypeganine | Inhibitor | / | Unkown |
| HY-108048A | Desoxypeganine hydrochloride | Inhibitor | / | Unkown |
| HY-114915 | PSB-1434 | Inhibitor | 98.05% | Unkown |
| HY-116097 | PSB-1491 | Inhibitor | / | Unkown |
| HY-119885A | (±)-Amiflamine | Inhibitor | 99.23% | Unkown |
| HY-129388C | Pulrodemstat hydrochloride | Inhibitor | / | Unkown |
| HY-129449 | AnnH31 | Inhibitor | 99.91% | Unkown |
| HY-131660 | MAO-B-IN-54 | Inhibitor | / | Unkown |
| HY-134664 | 8α-(2-Methylacryloyloxy)-hirsutinolide-13-O-acetate | Inhibitor | / | Unkown |
| HY-135265 | Moclobemide N-Oxide | Inhibitor | / | Unkown |
| HY-136878 | LSD1-IN-10 | Inhibitor | / | Unkown |
| HY-14198B | (±)-Selegiline hydrochloride | Inhibitor | / | Unkown |
| HY-14202 | Lazabemide hydrochloride | Inhibitor | 95.0% | Unkown |
| HY-143438 | 2-PAT | Inhibitor | / | Unkown |
| HY-144673 | LSD1-IN-12 | Inhibitor | / | Unkown |
| HY-144756 | LSD1-IN-15 | Inhibitor | / | Unkown |
| HY-144757 | LSD1-IN-16 | Inhibitor | / | Unkown |
| HY-144758 | LSD1-IN-17 | Inhibitor | / | Unkown |
| HY-149528 | MAO-B-IN-24 | Inhibitor | / | Unkown |
| HY-149978 | LSD1-IN-26 | / | Unkown | |
| HY-151094 | FTEAA | Inhibitor | / | Unkown |
| HY-151800 | MAO-A/B-IN-2 | Inhibitor | / | Unkown |
| HY-152109 | AChE/MAO-IN-1 | Inhibitor | / | Unkown |
| HY-152110 | AChE/MAO-IN-2 | Inhibitor | / | Unkown |
| HY-15386 | Cimoxatone | Inhibitor | / | Unkown |
| HY-157934 | MAO-IN-4 | Inhibitor | / | Unkown |
| HY-157981 | AChE-IN-60 | Inhibitor | / | Unkown |
| HY-157982 | BChE-IN-28 | Inhibitor | / | Unkown |
| HY-158092 | ChEs/MAOs-IN-2 | Inhibitor | / | Unkown |
| HY-158732 | MAO-B-IN-33 | Inhibitor | / | Unkown |
| HY-159106 | MeSeI | / | Unkown | |
| HY-161240 | MAO-B-IN-30 | Inhibitor | 98.53% | Unkown |
| HY-162606 | MAO-A/B-IN-3 | Inhibitor | / | Unkown |
| HY-162760 | COMT-IN-1 | Inhibitor | / | Unkown |
| HY-163322 | MAO-A inhibitor 2 | Inhibitor | / | Unkown |
| HY-163618 | DHMQ | / | Unkown | |
| HY-170487 | MAO-B-IN-38 | Inhibitor | / | Unkown |
| HY-174833 | MAO-A-IN-2 | Inhibitor | / | Unkown |
| HY-174834 | MAO-B-IN-44 | Inhibitor | / | Unkown |
| HY-176254 | LSD1-IN-43 | Inhibitor | / | Unkown |
| HY-176271 | MAO-B-IN-45 | / | Unkown | |
| HY-178149 | MAO-A/B-IN-5 | Inhibitor | / | Unkown |
| HY-178352 | MAO-B-IN-49 | / | Unkown | |
| HY-179126 | BChE/MAO-A-IN-1 | Inhibitor | / | Unkown |
| HY-180552 | AChE-IN-104 | Inhibitor | / | Unkown |
| HY-180783 | AChE/BChE/MAO-A-IN-1 | Inhibitor | / | Unkown |
| HY-180843 | Aβ/tau aggregation-IN-4 | Inhibitor | / | Unkown |
| HY-181110 | MAO-A-IN-4 | Inhibitor | / | Unkown |
| HY-182727 | MDL 72392 | Inhibitor | / | Unkown |
| HY-184159 | AChE/BChE/MAO-A-IN-2 | Inhibitor | / | Unkown |
| HY-186195 | Methyl-cudratricusxanthone B | / | Unkown | |
| HY-B0534S | Moclobemide-d8 | Inhibitor | / | Unkown |
| HY-B0534S1 | Moclobemide-d4 | Inhibitor | 99.0% | Unkown |
| HY-B0678S | Metaxalone-d3 | 98.0% | Unkown | |
| HY-B0678S1 | Metaxalone-d6 | / | Unkown | |
| HY-D3221 | MAO Probe 1 | / | Unkown | |
| HY-N1638 | 1-Methyl-2-undecyl-4(1H)-quinolone | Inhibitor | / | Unkown |
| HY-N18471 | 5,7-Dihydroxytryptamine | Ligand | / | Unkown |
| HY-N18471A | 5,7-Dihydroxytryptamine hydrobromide | Ligand | / | Unkown |
| HY-N18471B | 5,7-Dihydroxytryptamine creatinine sulfate | Ligand | / | Unkown |
| HY-RS08019 | MAOA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08020 | Maoa Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08021 | Maoa Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008566S | Norharmane-13C | / | Unkown | |
| HY-105041 | Tedizolid phosphate sodium | Inhibitor | / | Unkown |
| HY-105127 | Brofaromine hydrochloride | Inhibitor | / | Unkown |
| HY-124885 | MD 220661 | Inhibitor | / | Unkown |
| HY-14198S | Selegiline-d5 | Inhibitor | / | Unkown |
| HY-14199S | Selegiline-d5 hydrochloride | Inhibitor | / | Unkown |
| HY-160936 | 5-Hydroxyindoleacetaldehyde | / | Unkown | |
| HY-19333A | OG-L002 hydrochloride | Inhibitor | / | Unkown |
| HY-70057S4 | Safinamide-d5 | Inhibitor | / | Unkown |
| HY-N12134 | Methyl piperate | Inhibitor | / | Unkown |
| HY-N13041 | Acacetin 7-O-(6-O-malonylglucoside) | Inhibitor | / | Unkown |
| HY-W029600 | 6,7-Dimethylisatin | Inhibitor | / | Unkown |
| HY-W067583 | Norharmine | Inhibitor | / | Unkown |
| HY-W279140 | Pirlindole hydrochloride | Inhibitor | / | Unkown |
| HY-W700241 | Norharman-d7 | Inhibitor | / | Unkown |
| HY-W792513 | WAY-620147 | Inhibitor | 98.0% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service